CD8A and neoplasm: Furthermore, this also contributed to increased CD8+ T-cell infiltration in the orthotopic 4T1 tumor mouse model and similar effects on MDSCs and CD3+ and CD8+ cells in the BNL-R3 subcutaneous model, further supporting the contribution of EVT801 to anticancer immunity.